Key result
Direct intraperitoneal amiodarone administration resulted in survival beyond the neonatal period in 7 of 8 hydropic foetuses with refractory supraventricular tachycardia.
Why the study?
Does direct intraperitoneal amiodarone improve survival and rhythm outcomes in hydropic foetuses with resistant supraventricular tachycardia?
Population
8 hydropic foetuses with resistant supraventricular tachycardia, median gestational age 27+1 weeks, median…
Design
Case_series
Follow-up
beyond the neonatal period
Authors
Loading...
May warrant consideration in select refractory cases; leaves open prospective validation before practice change.
Case Report (n=8)
Does direct intraperitoneal amiodarone improve survival and rhythm outcomes in hydropic foetuses with resistant supraventricular tachycardia?
Intraperitoneal administration of amiodarone is an effective strategy for refractory fetal supraventricular tachycardia complicated by severe hydrops, resulting in high rates of sinus rhythm conversion and neonatal survival.
Kang et al. (2014) conducted a case report in Foetal supraventricular tachycardia with hydrops fetalis (n=8). Direct intraperitoneal amiodarone was evaluated on Survival beyond the neonatal period. Direct intraperitoneal amiodarone administration resulted in survival beyond the neonatal period in 7 of 8 hydropic foetuses with refractory supraventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: